Guohui Xu

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers

Daiwei Wan, Songbing He, Binhui Xie et al. · Medical Oncology · 2013 · 43 citations

Medicine, Molecular Biology, Oncology +16

A let-7 KRAS rs712 polymorphism increases colorectal cancer risk

Xin-Min Pan, Ruifen Sun, Zhaohui Li et al. · Tumor Biology · 2013 · 37 citations

Medicine, Genetics, Oncology +17

Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis

Xuegang Yang, Yan-Yuan Sun, Haiqing Wang et al. · Frontiers in Oncology · 2022 · 28 citations · Full text

Medicine, Oncology, Surgery +17

Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China

Yuntao Song, Guohui Xu, Tonghui Ma et al. · Cancer Medicine · 2020 · 27 citations · Full text

Medicine, Oncology, Pathology +17